<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00428649</url>
  </required_header>
  <id_info>
    <org_study_id>DK58763-opt</org_study_id>
    <secondary_id>R01DK058763</secondary_id>
    <nct_id>NCT00428649</nct_id>
  </id_info>
  <brief_title>Optimization of Selenoprotein P in Chinese Subjects</brief_title>
  <official_title>Optimization of Selenoprotein P in Chinese Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Vanderbilt University</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the amount of selenium as selenomethionine that is
      required to optimize selenoprotein P in selenium-deficient Chinese subjects
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Selenium is an essential nutrient. The Recommended Dietary Allowance (RDA) for selenium is
      considered to be the amount required to optimize plasma selenoproteins. There are two
      selenoproteins present in the plasma: selenoprotein P (Se-P) and glutathione peroxidase 3
      (GPX-3). Although the amount of selenium required to optimize GPX-3 has been determined, the
      amount required to optimize Se-P in the plasma remains unknown. We aim to determine this
      amount by supplementing selenium deficient subjects with varying amounts of selenium as
      selenomethionine.

      The study will take place in Mianning County, China, where selenium status is low.
      Approximately 150 people will be screened for eligibility to participate in this study. 98
      subjects will be enrolled. Background information obtained from each participant will be:
      age, height, weight and smoking status.

      Subjects will be randomized to a selenium supplement group. The selenium supplement will
      contain either 0, 20, 40, 60, 80, 100, or 120 µg of selenium as selenomethionine. A CDC
      worker will visit each participant daily to give them their selenium supplement. The CDC
      worker will watch them take their supplement and will ask if they have any unanticipated
      problems. Blood samples of 20 ml will be obtained at weeks 0, 4, 8, 12, 16, 20, 24, 32, and
      40. Hair samples and 24-hr urine collections will be obtained at 0, 20 and 40 weeks. The
      total study duration is 40 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">October 2008</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma selenoprotein P levels at 0, 4, 8, 12, 16, 20, 24, 32, and 40 weeks</measure>
    <time_frame>40 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total plasma selenium concentrations at 0, 4, 8, 12, 16, 20, 24, 32, and 40 weeks</measure>
    <time_frame>40 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma glutathione peroxidase activity at 0, 4, 8, 12, 16, 20, 24, 32, and 40 weeks</measure>
    <time_frame>40 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>24hr urinary selenium excretion at 0, 20 and 40 weeks</measure>
    <time_frame>40 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hair selenium levels at 0, 20 and 40 weeks</measure>
    <time_frame>40 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>7</number_of_arms>
  <enrollment type="Actual">98</enrollment>
  <condition>Selenium Deficiency</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 µg selenium as selenomethionine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>40 µg selenium as selenomethionine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>60 µg selenium as selenomethionine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>80 µg selenium as selenomethionine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>100 µg selenium as selenomethionine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>120 µg selenium as selenomethionine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>7</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>20 µg selenium</intervention_name>
    <description>20 µg selenium as selenomethionine</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>40 µg selenium</intervention_name>
    <description>40 µg selenium as selenomethionine</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>60 µg selenium</intervention_name>
    <description>60 µg selenium as selenomethionine</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>80 µg selenium</intervention_name>
    <description>80 µg selenium as selenomethionine</description>
    <arm_group_label>4</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>100 µg selenium</intervention_name>
    <description>100 µg selenium as selenomethionine</description>
    <arm_group_label>5</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>120 µg selenium</intervention_name>
    <description>120 µg selenium as selenomethionine</description>
    <arm_group_label>6</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>placebo</description>
    <arm_group_label>7</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  aged 17 years or older

          -  healthy

          -  resident of Mianning County for at least 1 year

          -  hematocrit (PCV) of 30 or greater

        Exclusion Criteria:

          -  subject has taken selenium supplements within the year prior to study

          -  subject plans to relocate during study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raymond F Burk, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yiming Xia, Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Sichuan CDC, Chengdu</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sichuan Center for Disease Control and Prevention (Sichuan CDC)</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Xia Y, Hill KE, Byrne DW, Xu J, Burk RF. Effectiveness of selenium supplements in a low-selenium area of China. Am J Clin Nutr. 2005 Apr;81(4):829-34.</citation>
    <PMID>15817859</PMID>
  </reference>
  <reference>
    <citation>Casey CE, Guthrie BE, Friend GM, Robinson MF. Selenium in human tissues from New Zealand. Arch Environ Health. 1982 May-Jun;37(3):133-5.</citation>
    <PMID>7092329</PMID>
  </reference>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 25, 2007</study_first_submitted>
  <study_first_submitted_qc>January 25, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2007</study_first_posted>
  <last_update_submitted>March 6, 2012</last_update_submitted>
  <last_update_submitted_qc>March 6, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 7, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University</investigator_affiliation>
    <investigator_full_name>RBurk</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>Selenium supplements</keyword>
  <keyword>Selenoprotein P</keyword>
  <keyword>Optimization</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Selenium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

